SEDAR Interim Financial Statements

TITAN LOGIX CORP. FISCAL 2026 FIRST QUARTER FINANCIAL REPORT UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the three-months ended November 30th, 2025 Notice of Reader of Interim Condensed Consolidated Financial Statements These interim condensed consolidated financial statements and related notes for the period ended November 30, 2025, have been prepared by and are the responsibility of management of Titan Logix Corp. The auditors of Titan Logix Corp. have not audited or reviewed these interim condensed consolidated financials. (Unaudited) (In 000's of CAD $, excluding per share amounts, except where otherwise noted) November 30, August 31, 2025 2025 $ $ 6,037 6,661 5,000 5,000 878 961 2,270 2,351 143 59 344 389 14,672 15,421 155 130 509 543 1,004 989 809 809 17,149 17,893 647 883 146 143 793 1,026 420 457 1,212 1,483 5,499 5,546 Treasury shares (note 10) (8) - 1,084 1,083 9,362 9,781 15,937 16,410 17,149 17,893 The accompanying notes are an integral part of these consolidated financial statements. On behalf of the Board Share capital Total current liabilities LIABILITIES AND SHAREHOLDERS’ EQUITY Non-current liabilities Total liabilities Shareholders’ equity Lease obligations Director Director Contributed surplus Retained earnings Total liabilities and shareholders’ equity “Helen Cornett” “Grant Reeves” Total shareholders’ equity Deferred tax assets Current liabilities Accounts payable and accrued liabilities Current portion of lease obligations Total assets Total current assets Current assets Inventories Prepaid expenses Cash and cash equivalents (note 5) Short term investments (note 5) Accounts receivable Property, plant and equipment Right-of-use assets Intangible assets Non-current assets Consolidated Statements of Financial Position Marketable securities ASSETS (In 000's of CAD $, excluding per share amounts, except where otherwise noted) For the three months ended November 30, 2025 2024 $ $ Revenue (note 13) 1,447 2,160 Cost of sales (860) (957) Gross profit 588 1,203 Expenses Selling, general and administrative expenses (584) (540) Engineering, product research and development expenses (339) (361) Depreciation and amortization expenses (note 6) (50) (76) Total expenses (972) (977) Operating earnings (loss) before other items (385) 226 Other items Other non-operating items (note 8) (45) (58) Finance income, net (note 7) 89 140 Total other items 44 82 Earnings (loss) before income taxes (340) 308 Income tax expense - (61) Earnings and comprehensive earnings (loss) (340) 246 Earnings (loss) per share, basic and diluted (note 9) (0.01) 0.01 Consolidated Statements of Earnings and Comprehensive Earnings (Loss) The accompanying notes are an integral part of these consolidated financial statements. (Unaudited) (In 000's of CAD $, excluding per share amounts, except where otherwise noted) Total Common Share Contributed Treasury Retained Shareholders’ Shares Capital Surplus Shares Earnings Equity # $ $ $ $ $ 27,584,373 5,546 1,083 - 9,782 16,411 - - 1 - - 1 Repurchase of common shares (note 10) (248,500) (47) (8) (79) (134) - - - - (340) (340) 27,335,873 5,499 1,084 (8) 9,362 15,937 Total Common Share Contributed Treasury Retained Shareholders’ Shares Capital Surplus Shares Earnings Equity # $ $ $ $ $ Balance at August 31, 2024 28,536,132 5,730 990 - 10,782 17,502 - - 7 - - 7 - - - - 246 246 28,536,132 5,730 997 - 11,028 17,756 Consolidated Statements of Changes in Shareholders’ Equity Balance at November 30, 2024 The --- accompanying notes are an integral part of these consolidated financial statements. Balance at August 31, 2025 Share-based compensation Earnings and comprehensive earnings Balance at November 30, 2025 Share-based compensation Earnings and comprehensive earnings (Unaudited) (In 000's of CAD $, excluding per share amounts, except where otherwise noted) For the three months ended November 30, 2025 2024 $ $ Cash provided by (used in) Operating activities Net earnings (loss) (340) 246 Non-cash items included in net earnings Gain on sale of marketable securities - (9) Depreciation of property, plant and equipment 9 10 Depreciation of right-of-use assets 34 36 Amortization of intangible assets 28 51 Unrealized loss on marketable securities 45 97 Unrealized gain on limited recourse capital notes - (30) Share-based compensation 1 7 Deferred tax asset utilization - 50 Finance income (note 7) (99) (153) Changes in non-cash working capital (note 11) (156) (490) Net cash used in operating activities (478) (184) Investing activities Proceeds from short term investments - 7,781 Finance income received (note 7) 99 153 Proceeds from the sale of marketable securities - 283 Purchase of property, plant and equipment (34) (6) Investment in intangible assets (43) (168) Net cash provided by investing activities 23 8,043 Financing activities Payment of principal portion of lease obligations (35) (32) Repurchase of common shares (note 10) (134) - Net cash used in financing activities (169) (32) Net increase (decrease) in cash and cash equivalents (625) 7,826 Cash and cash equivalents, beginning of period 6,661 3,292 Cash and cash equivalents, end of period 6,037 11,118 The accompanying notes are an integral part of these consolidated financial statements. Consolidated Statements of Cash Flows Notes to the Condensed Consolidated Interim Financial Statements For the three months ended November 30, 2025, and 2024 (Unaudited) (In 000’s of CAD $ excluding securities and per share amounts, except where otherwise noted) 1. NATURE OF OPERATIONS Titan Logix Corp. (the “Company”) is a public company incorporated and domiciled in Canada and its common shares trade on the TSX Venture Exchange under the symbol TLA. The head office for the Company is located in Edmonton, Alberta, Canada. The address of the Company’s registered office is #2600 10180 101 Street, Edmonton, AB T5J 3Y2. For over 25 years, Titan Logix Corp. has designed and manufactured mobile liquid measurement solutions to help businesses reduce risk and maximize efficiencies in bulk liquids transportation. Titan’s TD Series of tank level monitors are a market leader in mobile fluid measurement, and are known for their high level of accuracy, rugged design, and solid-state reliability. Our solutions are designed for hazardous and non-hazardous applications, and we serve customers in a wide range of applications including petroleum, environmental solutions, chemical, and agriculture. 2. BASIS OF PRESENTATION Statement of compliance These unaudited condensed consolidated interim financial statements for the three months ended November 30, 2025, and November 30, 2024, have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). They have been prepared in accordance with IAS 34, “Interim Financial Reporting” and do not contain all necessary annual disclosures in accordance with IFRS. The unaudited condensed consolidated --- interim financial statements of the Company for the three months ended November 30, 2025, were authorized for issue in accordance with a resolution of the directors on January 21, 2026. Principles of consolidation These unaudited condensed consolidated interim financial statements include the financial statements of Titan Logix Corp. and its wholly owned subsidiary, Titan Logix USA Corp. The financial statements for the subsidiary are prepared for the same reporting period as the parent company using consistent accounting policies. All intercompany transactions and balances have been eliminated in the preparation of these unaudited condensed consolidated interim financial statements. Functional and presentation currency The unaudited condensed consolidated interim financial statements are presented in Canadian dollars which is the functional currency of Titan Logix Corp. and its subsidiary. Comparative figures Certain prior period balances have been reclassified to conform with current period presentation. 3. SIGNIFICANT ACCOUNTING POLICIES These unaudited condensed consolidated interim financial statements, in all material respects, follow the same accounting policies and method of application as the annual audited consolidated financial statements of the preceding fiscal year. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with the annual consolidated financial statements for the year ended August 31, 2025. 4. FINANCIAL INSTRUMENTS – FAIR VALUE MEASUREMENT The Company’s financial instruments consist of cash and cash equivalents, short term investments, accounts receivable, marketable securities, limited recourse capital notes, accounts payable and accrued liabilities and lease liabilities. The carrying amounts of the current financial assets and current financial liabilities recognized in the Company’s consolidated financial statements at the end of the reporting period approximate their fair value due to their short period to maturity. Using the effective interest rate method, the fair value of the lease liability approximates the carrying value as the effective interest rates approximates the market interest rates. The fair value of the LRCNs is determined with reference to quoted market bids provided by a third-party independent dealer in the secondary market, as the LRCNs are not listed on any securities exchange. It has been determined that broker pricing is appropriate for these investments as there is sufficient trading volume to demonstrate that the fair values quotes are appropriate. Notes to the Condensed Consolidated Interim Financial Statements For the three months ended November 30, 2025, and 2024 (Unaudited) (In 000’s of CAD $ excluding securities and per share amounts, except where otherwise noted) 5. CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS Cash and cash equivalents include the following components: As at November 30, August 31, 2025 2025 $ $ Cash on hand and balances with banks 1,537 2,161 Guaranteed investment certificates (GICs) and other high interest deposits 9,500 9,500 Total cash and cash equivalents and short-term investments 11,037 11,661 Cash and cash equivalents 6,037 6,661 Short-term investments 5,000 5,000 Short term investments consist of guaranteed investment certificates (GICs) not cashable within three months of their acquisition. At November 30, 2025, GICs totalling $4,500 held by the Company were cashable within three months --- of their acquisition date with an underlying interest rate of 3.4% (2024 – 3.75% - 5.70%) classified as Cash and cash equivalents, and $5,000 not cashable within three months of their acquisition date, resulting in classification as Short-term investments with an underlying interest rate of 3.95% (2024 – N/A). 6. NATURE OF EXPENSES The Company presents certain expenses in the Condensed Consolidated Statements of Earnings and Comprehensive Earnings (Loss) by function. The following table presents these expenses by nature. For the three months ended November 30, 2025 2024 $ $ Employee salaries and benefits Included in cost of sales 171 148 Included in total expenses 610 603 Total employee salaries and benefits 780 751 Depreciation and amortization Amortization of right-of-use assets included in cost sales 19 20 Depreciation of property, plant and equipment included in cost of sales 3 2 Subtotal depreciation and amortization expenses included in cost of sales 22 21 Amortization of intangible assets included in total expenses 28 51 Amortization of right-of-use assets included in total expenses 16 16 Depreciation of property, plant and equipment included in total expenses 6 9 Subtotal depreciation and amortization expenses included total expenses 50 76 Total depreciation and amortization expenses 71 97 Notes to the Condensed Consolidated Interim Financial Statements For the three months ended November 30, 2025, and 2024 (Unaudited) (In 000’s of CAD $ excluding securities and per share amounts, except where otherwise noted) 7. FINANCE INCOME (NET) For the three months ended November 30, 2025 2024 $ $ Interest from investments in GICs and other high interest deposits 98 130 Interest from investments in LRCNs - 20 Other interest income 1 3 Subtotal, finance income: 99 153 Less: Interest expense on lease liabilities (10) (13) Total finance income (net) 89 140 8. OTHER NON-OPERATING ITEMS For the three months ended November 30, 2025 2024 $ $ Unrealized loss on marketable securities (45) (97) Unrealized gain on limited recourse capital notes - 30 Realized gain on sale of financial instruments - 9 Total other non-operating items (45) (58) 9. EARNINGS (LOSS) PER SHARE The following table sets forth the computation of basic and diluted earnings (loss) per share: For the three months ended November 30, 2025 2024 $ $ Net earnings (loss) (numerator for basic and diluted earnings per share) (340) 246 Weighted average number of shares outstanding - basic (denominator for basic earnings per share) 27,479,774 28,536,132 Effect of dilutive securities Stock options converted to common shares - 421,136 Weighted average number of shares outstanding - diluted (denominator for diluted earnings per share) 27,479,774 28,957,268 Basic earnings (loss) per share (0.01) 0.01 Effect of dilutive securities 0.00 0.00 Diluted earnings (loss) per share (0.01) 0.01 The average market value of the Company’s shares for the purposes of any dilutive calculations are based on quoted market prices for the period during which the options were outstanding. For the three months ended November 30, 2025, 1,300,000 of the total 1,550,000 outstanding options were “in-the-money” meaning that the exercise price was less than the average market price for the period, however, due to the net loss for the period ended November 30, 2025, all options outstanding, are considered anti-dilutive. For the three months ended November 30, 2024, all options were “in-the-money” and had a dilutive effect --- in the period. Notes to the Condensed Consolidated Interim Financial Statements For the three months ended November 30, 2025, and 2024 (Unaudited) (In 000’s of CAD $ excluding securities and per share amounts, except where otherwise noted) 10. SHARE CAPITAL Normal Course Issuer Bid (“NCIB”) During the period, the Company repurchased 248,500 common shares under its NCIB program, at an average price of $0.54 per share excluding transaction costs, for a total cost of $134. The carrying amount of the share capital repurchased, was $47 based on the average price of $0.20 per share. The excess of the purchase price over the carrying amount of the shares repurchased, totalling $79, was charged to retained earnings. Shares repurchased but not yet cancelled, totalling $8 representing 16,000 shares, are held as treasury shares. As at November 30, 2025, the Company has cumulatively repurchased 1,218,500 common shares under its NCIB program, at an average price of $0.71 per share, excluding transaction costs, for a total cash outlay of $893, inclusive of transaction costs. 11. CHANGE IN NON-CASH WORKING CAPITAL For the three months ended November 30, 2025 2024 $ $ Accounts receivable 83 (252) Inventories 81 (122) Prepaid expenses (84) 54 Income tax payable - 12 Accounts payable and accrued liabilities (236) (181) (156) (490) 12. RELATED PARTY TRANSACTIONS Key Management Personnel Compensation The Company’s key management personnel include its directors and executive. Compensation to key management personnel of the Company for the period was as follows: For the three months ended November 30, 2025 2024 $ $ Salaries and short-term employee benefits 185 193 Share-based compensation 1 7 186 200 During the three months ended November 30, 2025, and 2024, there were no long-term employee benefits or post-employment benefits recognized. Short-term employee benefits consist of salaries, consulting fees, bonuses, director fees, and all other short-term benefits. Notes to the Condensed Consolidated Interim Financial Statements For the three months ended November 30, 2025, and 2024 (Unaudited) (In 000’s of CAD $ excluding securities and per share amounts, except where otherwise noted) 13. SEGMENTED REPORTING The Company operates substantially all its activities in one reportable segment, mobile liquid measurement solutions, which include the developing, manufacturing and marketing of mobile liquid measurement solutions. Operating segments are defined as components of the Company for which separate financial information is available that is evaluated regularly by the chief operating decision makers in allocating resources and assessing performance. The chief operating decision maker of the Company is the Chief Executive Officer. Segmented information is provided on the basis of geographic segments as the Company sells into two primary geographic regions: Canada and the United States. 2025 2024 Revenues $ $ Canada 669 666 United States and other 779 1,494 1,447 2,160 For the three months ended November 30, 2025, revenue from a single customer made up 16% of total revenue (2024 – 21%). At November 30, 2025, all non-current assets were held in Canada. Corporate Address: 4130 – 93 Street NW Edmonton, Alberta, Canada T6E 5P5 Phone: (780) 462-4085; Fax: (780) 450-8369 Exchange Listing: The Toronto Venture Stock Exchange (TSX-V) Stock Symbol: TLA Investor Information: Investor Relations, Titan Logix Corp. 4130 – 93 Street NW Edmonton, Alberta, Canada T6E 5P5 Phone: ( --- 780) 462-4085; Fax: (780) 450-8369 Email: [email protected] Transfer Agent: Computershare Investor Services Inc. Stock Transfer Services 800, 324 – 8th Avenue SW, Calgary, Alberta, Canada T2P 2Z2 Telephone: 1-800-564-6253 Directors: S. Grant Reeves, BA Chairperson of the Board Helen Cornett, CPA, CA Audit Committee Chairperson Victor Lee, BSc E.E., BSc C.S. Executive Compensation and Corporate Governance Committee Chairperson Robert Tasker, BASc, Engineering, MBA Officers: Nicholas Forbes Chief Executive Officer Michael Martin, CPA, CA Chief Financial Officer Auditors: Kingston Ross Pasnak LLP www.titanlogix.com